| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/11/1986 | CA1200496A1 Oral dipyridamole forms |
| 02/11/1986 | CA1200494A1 Process of producing composition for long acting nicardipine preparation |
| 02/11/1986 | CA1200493A1 Pharmaceutical carrier and compositions |
| 02/11/1986 | CA1200492A1 Medicinal composition and method of making same |
| 02/05/1986 | EP0170642A2 Liposomes containing steroid esters |
| 02/05/1986 | EP0170540A1 Process for preparation of biodegradable microcapsules on the basis of serum albumin |
| 02/05/1986 | EP0170269A2 Medicated cosmetic compositions |
| 02/05/1986 | EP0170247A2 Hemoglobin-containing liposomes and process for preparing the same |
| 02/05/1986 | EP0170010A1 Self-adhesive plaster |
| 02/05/1986 | EP0169893A1 Encapsulation matrix composition and encapsulate containing same |
| 02/05/1986 | EP0169856A1 Veterinary implants |
| 02/04/1986 | US4568667 Aqueous preparation containing vitamin E and saponins |
| 02/04/1986 | US4568559 Composite core coated microparticles and process of preparing same |
| 02/04/1986 | US4568537 Acid released from gum stimulates salivary bicarbonates that neutralize harmful microbially formed acids |
| 02/04/1986 | US4568536 Mixture of calcium stearate, dextran and natural or synthetic oil or wax |
| 02/04/1986 | US4568535 Bactericide film |
| 02/04/1986 | US4568480 Microemulsions |
| 02/04/1986 | US4568343 Skin permeation enhancer compositions |
| 02/04/1986 | CA1200205A1 Polymeric diffusion matrix containing propranolol |
| 02/04/1986 | CA1200202A1 Salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants |
| 01/30/1986 | WO1986000538A2 Temperature- or fluid-sensitive devices |
| 01/30/1986 | WO1986000536A1 Bandage for sustained delivery of drugs |
| 01/30/1986 | WO1986000532A1 Silicone pressure sensitive adhesive and uses |
| 01/30/1986 | WO1986000530A1 Process for preparing gamma globulin suitable for intravenous administration |
| 01/30/1986 | WO1986000519A1 Drug intermittent release device |
| 01/30/1986 | WO1986000517A1 Methods and articles for treating peridontal disease |
| 01/29/1986 | EP0169821A2 Delivery device for zero-order release of an active principle into a dissolution fluid and process for its preparation |
| 01/29/1986 | EP0169700A2 Improved pharmaceutical formulations for ceftazidime |
| 01/29/1986 | EP0169658A1 Substained release dosage form |
| 01/29/1986 | EP0169618A2 Method for making uniformly sized particles from water-insoluble organic compounds |
| 01/29/1986 | EP0169466A2 Mixture of xanthin derivatives and O-acetyl-salicylic acid, or their pharmacologically acceptable salts, and its use |
| 01/29/1986 | EP0169398A2 Soft gelatin capsules containing oxytetracycline hydrochloride, and process for preparing them |
| 01/29/1986 | EP0169364A1 Self-adhesive plaster |
| 01/29/1986 | EP0169319A2 Maltodextrin coating |
| 01/29/1986 | EP0169236A1 Controlled release liquid dosage formulations for pharmaceuticals |
| 01/29/1986 | EP0169214A1 Anti-oestrogen drug for percutaneous administration. |
| 01/28/1986 | US4567161 Liquid active ingredient concentrates for preparation of microemulsions |
| 01/28/1986 | CA1199871A1 Drug preparations for glycoside hydrolase inhibitors |
| 01/28/1986 | CA1199870A1 Prolonged-action multiple-layer tablets |
| 01/28/1986 | CA1199869A1 Preparation of aqueous alcoholic dispersions of ph sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same |
| 01/28/1986 | CA1199755A1 Bactericidal tabletting composition and tablets formed therefrom |
| 01/22/1986 | EP0169105A2 Controlled porosity osmotic pump |
| 01/22/1986 | EP0168862A2 Biodegradable polymer substrates loaded with active substance suitable for the controlled release of the active substance by means of a membrane |
| 01/22/1986 | EP0168522A2 Active agent-containing shaped article |
| 01/22/1986 | EP0168506A1 Process for preparing gamma globulin suitable for intravenous administration |
| 01/22/1986 | EP0108073B1 Surgical accessory |
| 01/21/1986 | US4565696 Administering to produce antibodies |
| 01/21/1986 | US4565694 Contraceptive vaginal tablets |
| 01/21/1986 | US4565693 Deodorant composition |
| 01/21/1986 | US4565651 Stabilizer, saccharides, amino acids, sugar alcohols |
| 01/21/1986 | US4565580 Substrate consisting of regenerated collagen fibrils and method of manufacturing same |
| 01/21/1986 | CA1199581A1 Compressed chewable tablet and method for forming same |
| 01/16/1986 | WO1986000238A1 Extrusion techniques for producing liposomes |
| 01/16/1986 | WO1986000226A1 Dragee and method for its manufacture |
| 01/16/1986 | WO1986000225A1 Inhibition of tumor development |
| 01/15/1986 | EP0168360A2 Process for preparing etofibrate or similar compounds containing sustained release microgranules and products thus obtained |
| 01/15/1986 | EP0168277A1 Poly(orthoester)polymers containing pendant acid functionalities and labile backbone bonds |
| 01/15/1986 | EP0168229A2 Pharmaceutical antifungal composition |
| 01/15/1986 | EP0168214A2 Tumor necrosis factor, methods for its preparation, compositions containing it, DNA encoding it and assay method using such DNA |
| 01/15/1986 | EP0168044A2 Sustained release tablet |
| 01/15/1986 | EP0167958A2 Oral solid pharmaceutical form with sequential action for the administering of drugs with ulcerogenic side effect |
| 01/15/1986 | EP0167909A2 Solid pharmaceutical preparations containing dihydropyridine, and process for their manufacture |
| 01/15/1986 | EP0167840A1 Dietary composition |
| 01/15/1986 | EP0167834A2 Metal-containing polyaldehyde microspheres |
| 01/15/1986 | EP0167825A2 Lipid nano pellets as drug carriers for oral administration |
| 01/15/1986 | EP0167690A2 Droplet generation |
| 01/14/1986 | US4564364 Active agent dispenser |
| 01/14/1986 | US4564363 Delayed action assembly |
| 01/14/1986 | US4564362 Open-celled foam for use with medicines and contraceptives |
| 01/14/1986 | CA1199272A1 Topical antimicrobial composition |
| 01/08/1986 | EP0167363A2 Crosslinked glycosaminoglycans and their use |
| 01/08/1986 | EP0167263A1 Drug-containing matrices for introduction into cellular lesion areas |
| 01/08/1986 | EP0167191A1 A therapeutic preparation having ammonium nitrate as its active substance |
| 01/08/1986 | EP0167184A1 Solid substrate which consists at least partically of a biologically or chemically active substance and is coated with a (meth)acrylic polmeric network as well as a process for providing said coated substrate |
| 01/08/1986 | EP0167146A2 Primycin salts, method for their preparation and pharamaceutical preparations obtained |
| 01/08/1986 | EP0166946A1 Cosmetic product |
| 01/07/1986 | US4563489 Biodegradable organic polymer delivery system for bone morphogenetic protein |
| 01/07/1986 | US4563354 Fraction of soybean lecithin as emulsifier |
| 01/07/1986 | US4563351 Self-gelling therapeutic compositions for topical application |
| 01/07/1986 | US4563345 Tooth decay inhibiting fluoride |
| 01/07/1986 | US4563182 Rectal insert |
| 01/07/1986 | CA1198861A1 Process for molding capsules and capsules produced thereby |
| 01/03/1986 | WO1986000004A1 Improvement in the flavor of zinc supplements for oral use |
| 01/02/1986 | EP0166596A2 Biodegradable amphipathic copolymers |
| 01/02/1986 | EP0166529A1 Stabilized insulin formulation |
| 01/02/1986 | EP0166440A2 Antacid composition |
| 01/02/1986 | EP0166315A2 Gastro-resistant cylindrical pancreatine-microtablets |
| 01/02/1986 | EP0166061A2 Ophthalmic gel, and manufacturing process therefor |
| 01/02/1986 | EP0166056A2 Pharmaceutical dosage unit |
| 12/31/1985 | US4562075 Penetration enhancers for transdermal drug delivery of systemic agents |
| 12/31/1985 | US4562069 Nifedipine in amorphous and crystalline form for cardiovascular disorders and hypotensive agents |
| 12/31/1985 | US4562061 Pharmaceutical preparation |
| 12/31/1985 | US4562024 Process for preparing granulate containing poorly compressible medicinally active matter |
| 12/31/1985 | US4561991 Fabric cleaning compositions for clay-based stains |
| 12/31/1985 | CA1198679A1 Pharmaceutical compositions for promoting healing of wounds |
| 12/31/1985 | CA1198677A1 Stable plurilamellar vesicles |
| 12/27/1985 | EP0165696A2 Improved transdermal dosage form |
| 12/27/1985 | EP0165457A2 Cosmetic-oil component |
| 12/27/1985 | EP0165352A2 Clear micellized solutions of fat soluble essential nutrients |
| 12/27/1985 | EP0165275A1 Drug with improved penetration into the tissular membrane |